Put Options

21 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $101,280 - $131,808
4,800 New
4,800 $120,000
Q4 2022

Feb 14, 2023

SELL
$19.95 - $29.96 $341,145 - $512,316
-17,100 Reduced 78.44%
4,700 $95,000
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $538,460 - $634,816
21,800 New
21,800 $559,000
Q1 2022

May 16, 2022

SELL
$16.53 - $25.21 $34,713 - $52,941
-2,100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$17.1 - $23.34 $23,940 - $32,676
-1,400 Reduced 40.0%
2,100 $42,000
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $5,904 - $6,759
300 Added 9.38%
3,500 $69,000
Q1 2021

May 17, 2021

SELL
$23.49 - $30.56 $44,631 - $58,064
-1,900 Reduced 37.25%
3,200 $76,000
Q4 2020

Feb 16, 2021

SELL
$16.78 - $27.3 $31,882 - $51,870
-1,900 Reduced 27.14%
5,100 $133,000
Q2 2020

Aug 14, 2020

BUY
$11.0 - $18.26 $77,000 - $127,820
7,000 New
7,000 $118,000
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $2,022 - $2,808
-200 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$12.06 - $16.96 $27,738 - $39,008
-2,300 Reduced 92.0%
200 $2,000
Q3 2019

Nov 14, 2019

SELL
$10.41 - $14.66 $118,674 - $167,124
-11,400 Reduced 82.01%
2,500 $35,000
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $96,822 - $126,324
-9,900 Reduced 41.6%
13,900 $155,000
Q1 2019

May 15, 2019

BUY
$10.03 - $15.71 $238,713 - $373,898
23,800 New
23,800 $279,000
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $6,773 - $10,314
-600 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$12.27 - $15.65 $294,480 - $375,600
-24,000 Reduced 97.56%
600 $8,000
Q2 2018

Aug 14, 2018

SELL
$15.3 - $19.69 $448,290 - $576,917
-29,300 Reduced 54.36%
24,600 $387,000
Q1 2018

May 15, 2018

BUY
$14.59 - $25.5 $786,401 - $1.37 Million
53,900 New
53,900 $887,000
Q4 2017

Feb 14, 2018

SELL
$15.77 - $20.72 $25,232 - $33,152
-1,600 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $15,990 - $25,090
1,300 Added 433.33%
1,600 $32,000
Q2 2017

Aug 14, 2017

BUY
N/A
300
300 $3,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.